Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism PlA2 in patients with central retinal vein occlusion.

Thrombosis research - 15 Nov 1999

Larsson J, Hillarp A

Abstract excerpt

The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism PlA2 have been shown to be associated with thromboembolic disease. We wondered if mutations were overrepresented in patients with central retinal vein occlusion. We studied 129 consecutive patients with a history of central retinal vein occlusion. We analysed for the prothrombin gene G20210A mutation and the platelet...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to Blood Platelets
Share to Integrin beta3

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Integrins

Share to Platelet Membrane Glycoproteins

Share to Point Mutation

Share to Prothrombin

Share to Retinal Vein Occlusion

Source

Identifiers

PMID: 10593436
DOI: 10.1016/s0049-3848(99)00111-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism PlA2 in patients with central retinal vein occlusion.PMID 10593436Read ↗

Central retinal vein thrombosis associated with prothrombin 20210G/A gene variant.Semantic proximity Read ↗

Factor V Leiden and prothrombin 20210 A mutations in patients with central and branch retinal vein occlusion.Semantic proximity Read ↗

Role of factor V Leiden and prothrombin 20210A in patients with retinal artery occlusion.Semantic proximity Read ↗

Idiopathic central retinal vein occlusion in 2 siblings with the 20210 G-->A prothrombin variant.Semantic proximity Read ↗

Factor V and antithrombin gene mutations in patients with idiopathic central retinal vein occlusion.Semantic proximity Read ↗

Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.Semantic proximity Read ↗

The heterozygous 20210 G/A genotype prevalence in patients affected by central and branch retinal vein occlusion: a pilot study.Semantic proximity Read ↗

[Central retinal vein occlusion in a factor V leiden and G21210A prothrombin variant carrier].Semantic proximity Read ↗

Branch retinal vein occlusion associated with the 20210 G-to-A prothrombin variant.Semantic proximity Read ↗

Thrombophilic mutations and risk of retinal vein occlusion.Semantic proximity Read ↗

Ocular artery thrombosis as an initial presentation of a prothrombin G20210A mutation.Semantic proximity Read ↗

Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.